Bhutan vs China: Hepatitis B surface antigen (HBsAg) prevalence
Bhutan
0.1%
in 2024
China
0.1%
in 2024
Bhutan rank
101st
China rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Bhutan
- China
How they compare
Bhutan currently reports 0.1% against 0.1% in China, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Bhutan ahead.
Bhutan ranks 101st and China ranks 101st of 194 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.0% | China |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Bhutan or China?
- Bhutan, at 0.1% against 0.1% in China as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Bhutan and China?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and China?
- 10 years are reported by both, from 2015 to 2024.
- How do Bhutan and China rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Bhutan ranks 101st and China ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.